Cartesian Therapeutics Reports Third Quarter 2026 Financial Results and Business Update

Article summary

Cartesian Therapeutics announced its financial results for the third quarter ended September 30, 2026, and provided updates on its clinical pipeline, including the Phase 3 AURORA trial for Descartes-08.